β-Adrenoceptor blockade prevents carotid body hyperactivity and elevated vascular sympathetic nerve density induced

Abdulaziz A Alzahrani1,2, Lily L Cao1,3, Hayyaf S Aldossary1,4

  • 1Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

Insights

Beta-blocker treatment with propranolol prevented carotid body (CB) hyperactivity, sympathetic nerve growth, and hypertension caused by chronic intermittent hypoxia (CIH). This highlights a new role for beta-adrenergic stimulation in CIH-induced cardiovascular changes.

Area of Science:

  • Cardiovascular Physiology
  • Neuroendocrinology
  • Respiratory Physiology

Background:

  • Carotid body (CB) hyperactivity contributes to hypertension during chronic intermittent hypoxia (CIH).
  • Adrenaline is elevated in CIH and may activate the CB, but chronic adrenergic stimulation's role is unclear.
  • Beta-adrenergic receptors (β1 and β2) are present on CB type I cells.

Purpose of the Study:

  • To investigate if propranolol (a beta-blocker) prevents CB hyperactivity, vascular sympathetic nerve growth, and hypertension induced by CIH.
  • To determine the role of chronic beta-adrenergic stimulation in mediating CB hyperactivity.

Main Methods:

  • Adult male Wistar rats were divided into Control, Control+Propranolol, CIH, and CIH+Propranolol groups.
  • CIH was induced for 3 weeks (8 cycles/hr, 8 hrs/day).
  • Propranolol was administered (40 mg/kg/day) via drinking water; immunohistochemistry and physiological measurements were performed.

Main Results:

  • CIH increased basal CB chemoafferent activity 2-3 fold, which was prevented by propranolol.
  • Propranolol attenuated chemoafferent responses to hypoxia and mitochondrial inhibitors, especially in CIH animals.
  • Propranolol reduced respiratory frequency, abolished CIH-induced increases in vascular sympathetic nerve density, and altered blood pressure responses during hypoxia.

Conclusions:

  • Chronic beta-adrenergic stimulation plays a significant role in CB hyperactivity, sympathetic vascular hyperinnervation, and altered blood pressure control during CIH.
  • Propranolol treatment effectively mitigated key pathological changes induced by CIH.
  • These findings identify novel mechanisms involving beta-adrenergic pathways in the cardiovascular consequences of CIH.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.2K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.4K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
6.2K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.1K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
987
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.7K